DermTech International's Series C Round

DermTech International raised a round of funding on August 14, 2015.

DermTech develops and commercializes qPCR assays for skin samples collected non-invasively using adhesive tape biopsy methods. The company's assays can analyze multiple gene targets to assess their le…

Articles about DermTech International's Series C Round: